PPB - Services

Complaints, Feedback and Enquiry

PUBLIC ALERT ON BENYLIN PAEDIATRIC 1OOMLs COUGH SYRUP, BATCH NO. 329304 MANUFACTURED BY JOHNSON & JOHNSON (Pty), SOUTH AFRICA

[featured_image]
  • Version
  • Download 41
  • File Size 1.11 MB
  • File Count 1
  • Create Date April 12, 2024
  • Last Updated April 12, 2024

PUBLIC ALERT ON BENYLIN PAEDIATRIC 1OOMLs COUGH SYRUP, BATCH NO. 329304 MANUFACTURED BY JOHNSON & JOHNSON (Pty), SOUTH AFRICA

The Pharmacy and Poisons Board (PPB) wishes to inform the public that it has received information regarding a medical product alert and recall of Benylin pediatric 100mls cough syrup Batch No 329304, by the National Agency for Food and Drug Administration and Control (NAFDAC) of Nigeria. This cough syrup manufactured by Johnson & Johnson (Pty), South Africa, is being recalled due to quality concerns arising from an unacceptable high level of diethyleneglycol detected through laboratory analysis conducted by NAFDAC. Diethyleneglycol is a contaminant which is toxic to humans when consumed and can prove fatal. Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.

Attached Files

FileAction
PUBLIC ALERT ON BENYLIN PAEDIATRIC 1OOMLs COUGH SYRUP, BATCH NO. 329304 MANUFACTURED BY JOHNSON & JOHNSON (Pty), SOUTH AFRICA.pdfDownload

Author

Tony Kemboi

Leave a comment

Your email address will not be published. Required fields are marked *